GlassScriptPhysician profile
Gregory D Carlson
NPI 1215924329
$14,340.66
in general payments reported to CMS, 2019-2025
43 companies · $992 in 2025
The $992 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $400 · 2021: $7,237 · 2022: $3,172 · 2023: $954 · 2024: $1,086 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,031.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,435.52 | 2021 | |
| Nuvasive, INC. | $1,963.07 | 2019-2023 | Versatie, Xlif, Simplify Cervical Artificial Disc |
| Djo, LLC | $1,671.32 | 2022 | |
| Globus Medical, INC. | $1,454.65 | 2024-2025 | Creo, Aerial, Altera |
| Gemini Medical LLC | $1,200.00 | 2021 | |
| Depuy Synthes Sales INC. | $777.74 | 2019-2022 | |
| Abbott Laboratories | $400.83 | 2021-2023 | Proclaim |
| Electronic Waveform Lab, INC. | $310.18 | 2021-2022 | |
| Integra Lifesciences Corporation | $300.73 | 2019-2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Spineart USA INC | $215.63 | 2021 | |
| Medtronic, INC. | $176.56 | 2022-2025 | Intellis Adaptivestim, Minimed 780g |
| Stryker Corporation | $165.53 | 2019-2021 | |
| Abbvie INC. | $155.85 | 2023-2024 | Botox |
| Ethicon US, LLC | $120.79 | 2021-2025 | Dermabond Prineo, Evarrest |
| Relievant Medsystems, INC. | $101.10 | 2023 | Intracept |
Show all 42 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$206,009.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.